Funding to accelerate AI-driven automation, easing burdens on healthcare staff and improving patient care delivery.
Qventus, a healthtech in AI-based care automation, has achieved a major milestone, announcing $105M in Series D funding led by global investment firm KKR. The funding round also saw participation from Bessemer Venture Partners and new strategic investors HonorHealth, Northwestern Medicine, and Allina Health. This substantial investment will enable Qventus to further its mission of transforming healthcare operations through innovative AI-driven automation that alleviate administrative burdens and enhance efficiency.
Healthcare systems across the globe face challenges stemming from manual, fragmented, and outdated processes, leaving frontline staff overworked and limiting their ability to provide optimal care. Picture a healthcare system where AI identifies bottlenecks, recommends solutions, and even resolves issues autonomously—this is the transformative vision Qventus is bringing to life.
Empowering healthcare providers with AI-driven automation
At the heart of Qventus’ offerings is its AI-first care operations automation platform. The AI-driven automation platform has been deployed across leading health systems, addressing operational inefficiencies in both inpatient and outpatient settings. By leveraging Generative AI, machine learning, and behavioural science, Qventus predicts operational challenges, recommends actionable remedies, and automates complex workflows, thereby empowering healthcare teams to focus on patient care.
“Across the country, healthcare teams have to do extraordinary things to get ordinary things done every single day,” said Mudit Garg, CEO and Co-Founder of Qventus. “Qventus has dedicated the last decade to building AI automation solutions that alleviate the administrative burden of healthcare staff so they can deliver highly reliable patient care.”
The company’s flagship solutions include its Surgical Growth and Inpatient Capacity products, which are already making a significant impact on clinical operations. In 2024, Qventus’ platform supported more than half a million surgeries and helped increase robotic-assisted procedures by 35%. Its Inpatient Capacity solution, designed to reduce patient length of stay and create additional capacity, eliminated over 36,000 excess patient days, saving healthcare systems millions of dollars.
Scaling AI-driven automation for healthcare
With the new funding, Qventus plans to extend its platform’s capabilities beyond its existing solutions to address inefficiencies in other areas of the patient journey. This will involve launching new AI Operational Assistants to manage workflows both upstream and downstream of surgical and inpatient settings, building on the success of its current offerings.
“This funding is a testament to how these solutions generate best-in-industry return on investment, helping health systems achieve the margins needed to fulfil their mission of delivering exceptional care to their communities,” said Garg, “This capital primes us to continue maximising our growth, delivering on our promises to our partners, and launching new, game-changing technology.”
These AI-driven automation “teammates” enhance team productivity by up to 50%, helping care teams identify potential issues, recommend interventions, and take proactive actions. The goal is not just to identify problems but to create solutions that seamlessly integrate into healthcare workflows, reducing the cognitive load on staff and ensuring optimal patient outcomes.
A decade of innovation and resilience
Founded in 2012, Qventus has built a reputation as a trusted partner for health systems, independent hospitals, and academic medical centres. The company’s commitment to delivering measurable outcomes has earned it industry recognition, including a 92.5% overall KLAS score in 2024 and Frost & Sullivan’s Best Practices Customer Value Leadership Award.
“Built on a solid foundation, Qventus has navigated the evolving care landscape and emerged resilient, thanks to its sophisticated technology and proprietary data engine built over the last decade,” said Jake Heller, Partner and Head of Tech Growth Equity, Americas at KKR. “We believe Qventus is well-positioned to be a market leader in supporting care delivery at the provider level and redefining the future of health care by supporting hospital systems in operating more efficiently so they can focus on what really matters–quality care for patients.”
The company’s approach to AI is both systematic and targeted. Rather than offering a one-size-fits-all solution, Qventus focuses on deeply understanding specific use cases to deliver impactful outcomes. Its platform integrates seamlessly with electronic health records (EHRs) and uses a combination of advanced technologies to address pain points such as scheduling inefficiencies, administrative redundancies, and patient flow challenges.
Positioning for future growth
One of the unique aspects of this funding round is that Qventus was not actively seeking capital. According to Garg, the company’s success and the enthusiasm of its partners naturally led to the opportunity.
“We were not explicitly seeking it out,” said Garg. “Both our existing investors were excited and were prompting like, “Hey, we can put more capital in,” and other external folks had been excited and sort of reaching out and asking, “If we’re interested in it.””
This additional funding will enable Qventus to invest in areas that anticipate future needs rather than reacting to immediate challenges. The company aims to remain at the forefront of healthcare innovation, helping providers adapt to an increasingly complex and dynamic care landscape.
Driving meaningful impact for healthcare providers
Qventus’ solutions are not just about implementing AI but about creating tangible value for healthcare systems. In 2024 alone, the company’s Surgical Growth solution generated $95M in annualised contribution margin by enabling hospitals to optimise surgical schedules and address gaps in care delivery.
“By collaborating with Qventus, Northwestern Medicine has been able to significantly address capacity and access demands for our operating rooms, which has allowed our patients quicker access to care,” said Doug King, Senior Vice President and Chief Information Officer at Northwestern Medicine.
As Qventus looks to the future, it remains committed to its mission of empowering healthcare providers with innovative AI solutions that drive efficiency, reduce burnout, and improve patient outcomes. With the backing of KKR’s Next Generation Technology III Fund, the company is poised to redefine healthcare operations and deliver lasting impact for providers and patients alike.
The post AI-driven automation enhances healthcare as Qventus secures $105M Series D appeared first on Tech Funding News.